Amylyx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Amylyx Pharmaceuticals, Inc. has filed 414 SEC EDGAR filings since 17 Nov 2015

SEC filing history

Showing 76-100 of 414 matching filings.

Per page
25
Current page
4
SCHEDULE 13G/A File 005-93265

SCHEDULE 13G/A filing

Filing date
30 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93265

SCHEDULE 13G filing

Filing date
07 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-285525

424B5

Filing date
10 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-285525

424B5

Filing date
09 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Aug 2025
Reporting date
12 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41199

144 filing

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93265

SCHEDULE 13G/A filing

Filing date
12 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93265

SCHEDULE 13G filing

Filing date
29 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93265

SCHEDULE 13G filing

Filing date
17 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-93265

SCHEDULE 13G filing

Filing date
25 Jun 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
09 Jun 2025
Reporting date
05 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .